Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
98.5M
-
Shares change
-
-4.63M
-
Total reported value, excl. options
-
$631M
-
Value change
-
-$31.7M
-
Put/Call ratio
-
1.17
-
Number of buys
-
109
-
Number of sells
-
-102
-
Price
-
$6.41
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q1 2025
320 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q1 2025.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98.5M shares
of 162M outstanding shares and own 60.72% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.7M shares), BlackRock, Inc. (13M shares), SHAH CAPITAL MANAGEMENT (11.1M shares), STATE STREET CORP (7.04M shares), Sanofi (6.88M shares), COATUE MANAGEMENT LLC (3.84M shares), GEODE CAPITAL MANAGEMENT, LLC (3.76M shares), D. E. Shaw & Co., Inc. (3.26M shares), Park West Asset Management LLC (2.53M shares), and MORGAN STANLEY (1.98M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.